UK registered SMEs can apply for a share of up to £15 million to develop innovative solutions to health, and healthcare, challenges. This funding is from Innovate UK.
Competition closes: Wednesday 16 October 2024 11:00am
Innovate UK, part of UK Research and Innovation, will work with the Department of Health and Social Care (DHSC) to invest up to £15 million to support the development and adoption of sustainable technologies for the manufacturing of medicines.
Competition closes: Wednesday 16 October 2024 11:00am
UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable R&D innovations that can significantly impact the UK economy. This funding is from Innovate UK, part of UK Research and Innovation.
Competition closes: Wednesday 23 October 2024 11:00am
Innovate UK EDGE’s highly regarded Scaleup Programme provides oneto-one, bespoke and fully funded support centered around innovative scaleups’ specific needs. It is available to those companies achieving, or with the potential for, 50% compound annual growth rates (CAGR) and over.
The Scaleup Programme helps the highest potential businesses realise their ambitions. Delivering growth at scale is at the heart of Innovate UK’s emerging strategy for business innovation in the UK. Innovate UK EDGE is a key enabler of this strategic priority and through the Scaleup Programme, helps the highest potential businesses realise their ambitions.
Deadline: None specified
Funding: Not specified
UKRI
Funding type: Grant
Award range: £400,000 – £1,500,000
Competition closes: 12 December 2024 4:00pm
Funding type: Grant
Award range: £400,000 – £1,500,000
Competition closes: 31 March 2025 4:00pm
NIHR
The EME Programme primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’. Current calls here include Cystic Fibrosis, Novel strategies to reduce overtreatment, Paediatric Care among others.
Deadline: None specified
Funding: Discretionary
The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness and broader impact of healthcare treatments and tests for those who plan, provide or receive care from NHS and social care services. They have a number of themed calls, please refer their website for more information.
Deadline: None specified
Funding: Discretionary
Other opportunities
BHF provide personal support for clinical and non-clinical cardiovascular researchers at all stages of their career. They also provide grants for short and long term research projects, essential infrastructure and strategic initiatives.
Deadline: None specified
Funding: Not available
Nesta Impact Investments is a £17.6m fund investing in life changing innovations that help tackle the major challenges faced by older people, children and communities in the UK.
Deadline: None specified
Funding: £1,000,000
The Global Innovation Fund is a non-profit innovation fund headquartered in London with an office in Washington D.C. that invests in the development, rigorous testing, and scaling of innovations targeted at improving the lives of the world’s poorest people. Through our grants and risk capital, we help breakthrough solutions to global development challenges from for profit firms, non profit organisations, researchers, and government agencies to maximise their impact and affect meaningful change.
Deadline: None specified
Funding: Discretionary